deferoxamine has been researched along with bathocuproine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buettner, GR; Kerber, RE; Lindower, PD; Spencer, KT | 1 |
| Canistro, D; Ganini, D; Jang, J; Jiang, J; Kadiiska, MB; Mason, RP; Stadler, K | 1 |
2 other study(ies) available for deferoxamine and bathocuproine
| Article | Year |
|---|---|
Transition metal chelators reduce directly measured myocardial free radical production during reperfusion.
Topics: Animals; Chelating Agents; Copper; Deferoxamine; Dogs; Free Radicals; Hemodynamics; Iron; Myocardial Reperfusion; Myocardium; Phenanthrolines | 1998 |
Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.
Topics: Animals; Artifacts; Biological Assay; Catalase; Ceruloplasmin; Chelating Agents; Deferoxamine; Edetic Acid; Free Radicals; Heparin; Humans; Hydroxylamines; Oxidants; Oxidation-Reduction; Pentetic Acid; Phenanthrolines; Rats; Superoxide Dismutase | 2012 |